DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $264,226 | +3.4% | 1,065 | 0.0% | 0.01% | +25.0% |
Q2 2023 | $255,600 | -2.0% | 1,065 | +2.9% | 0.00% | 0.0% |
Q1 2023 | $260,861 | -9.4% | 1,035 | -4.6% | 0.00% | -20.0% |
Q4 2022 | $287,981 | -18.4% | 1,085 | -20.5% | 0.01% | -28.6% |
Q3 2022 | $353,000 | +2.0% | 1,365 | 0.0% | 0.01% | +16.7% |
Q2 2022 | $346,000 | -15.2% | 1,365 | -1.8% | 0.01% | 0.0% |
Q1 2022 | $408,000 | -10.7% | 1,390 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $457,000 | +9.6% | 1,390 | +1.5% | 0.01% | 0.0% |
Q3 2021 | $417,000 | +13.3% | 1,370 | 0.0% | 0.01% | +20.0% |
Q2 2021 | $368,000 | +8.2% | 1,370 | -9.3% | 0.01% | 0.0% |
Q1 2021 | $340,000 | +1.5% | 1,510 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $335,000 | -8.2% | 1,510 | -10.9% | 0.01% | -28.6% |
Q3 2020 | $365,000 | +21.7% | 1,695 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $300,000 | +27.7% | 1,695 | 0.0% | 0.01% | 0.0% |
Q1 2020 | $235,000 | -17.5% | 1,695 | -8.6% | 0.01% | 0.0% |
Q4 2019 | $285,000 | +6.3% | 1,855 | 0.0% | 0.01% | 0.0% |
Q3 2019 | $268,000 | -7.9% | 1,855 | -8.8% | 0.01% | 0.0% |
Q2 2019 | $291,000 | +8.2% | 2,035 | 0.0% | 0.01% | 0.0% |
Q1 2019 | $269,000 | +28.1% | 2,035 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $210,000 | -5.0% | 2,035 | 0.0% | 0.01% | +16.7% |
Q3 2018 | $221,000 | +10.0% | 2,035 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $201,000 | -9.9% | 2,035 | -28.8% | 0.01% | -60.0% |
Q4 2016 | $223,000 | -0.4% | 2,860 | 0.0% | 0.02% | 0.0% |
Q3 2016 | $224,000 | -22.5% | 2,860 | 0.0% | 0.02% | -28.6% |
Q2 2016 | $289,000 | +5.1% | 2,860 | -1.4% | 0.02% | +10.5% |
Q1 2016 | $275,000 | +2.2% | 2,900 | 0.0% | 0.02% | -13.6% |
Q4 2015 | $269,000 | +4.3% | 2,900 | -4.3% | 0.02% | +4.8% |
Q3 2015 | $258,000 | -0.4% | 3,030 | 0.0% | 0.02% | +16.7% |
Q2 2015 | $259,000 | +0.8% | 3,030 | 0.0% | 0.02% | 0.0% |
Q1 2015 | $257,000 | -1.2% | 3,030 | 0.0% | 0.02% | 0.0% |
Q4 2014 | $260,000 | +15.6% | 3,030 | +2.5% | 0.02% | +12.5% |
Q3 2014 | $225,000 | -28.1% | 2,955 | -25.6% | 0.02% | -23.8% |
Q2 2014 | $313,000 | +2.0% | 3,970 | -3.1% | 0.02% | +10.5% |
Q1 2014 | $307,000 | -2.8% | 4,095 | 0.0% | 0.02% | -9.5% |
Q4 2013 | $316,000 | +10.1% | 4,095 | -1.0% | 0.02% | -16.0% |
Q3 2013 | $287,000 | +16.7% | 4,135 | +6.4% | 0.02% | 0.0% |
Q2 2013 | $246,000 | +10.3% | 3,885 | +8.4% | 0.02% | +4.2% |
Q1 2013 | $223,000 | – | 3,585 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |